Abstract:Toxoplasma gondii is an obligate intracellular parasite that infects one-third of the world's human population and establishes infection in the brain. Cerebral immune cell infiltration is critical for controlling the parasite, but little is known about the molecular cues guiding immune cells to the brain during infection. Activated astrocytes produce CCL2, a chemokine that mediates inflammatory monocyte recruitment to tissues by binding to the CCR2 receptor. We detected elevated CCL2 production in the brains of C57BL/6J mice by 15 days after T . gondii infection. Utilizing confocal microscopy and intracellular flow cytometry, we identified microglia and brain-infiltrating myeloid cells as the main producers of CCL2 during acute infection, and CCL2 was specifically produced in regions of parasite infection in the brain. In contrast, astrocytes became the dominant CCL2 producer during chronic T . gondii infection. To determine the role of astrocyte-derived CCL2 in mobilizing immune cells to the brain and controlling T . gondii infection, we generated GFAP-Cre x CCL2 fl/fl mice, in which astrocytes are deficient in CCL2 production. We observed significantly decreased immune cell recruitment and increased parasite burden in the brain during chronic, but not acute, infection of mice deficient in astrocyte CCL2 production, without an effect on peripheral immune responses. To investigate potential mechanisms explaining the reduced control of T . gondii infection, we analyzed key antimicrobial and immune players in host defense against T . gondii and detected a reduction in iNOS + myeloid cells, and T . gondii -specific CD4 + T cells in the knockout mice. These data uncover a critical role for astrocyte-derived CCL2 in immune cell recruitment and parasite control in the brain during chronic, but not acute, T . gondii infection. Neuroinflammation plays an important role in protecting the brain against infection, but it must be controlled to prevent damage to the brain. Toxoplasma gondii is an obligate intracellular foodborne parasite that infects one-third of the world's human population. Among pathogens, T . gondii has the rare ability to cross the blood-brain barrier and establish chronic infection in the brain, inducing a protective, but non-sterilizing immune response. In this study, we examined T . gondii infection of mice to understand the factors driving the neuroinflammatory response to infection of the brain. We determined that the cells producing the potent chemokine, CCL2, changed over the course of infection: myeloid cells were the main CCL2 producers during acute infection, whereas astrocytes became the dominant CCL2 producers during chronic infection. Additionally, the ablation of CCL2 production specifically from astrocytes reduced immune cell recruitment to the brain and decreased control of the parasite during chronic infection. Therefore, astrocyte-derived CCL2 plays a critical role in the control of chronic, but not acute, T . gondii infection.

Toxoplasma gondii infection supports the infiltration of T cells into brain tumors

Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth

Expression of immunoproteasome subunits in the brains of Toxoplasma gondii-infected mice

The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development

Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain

The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐T. Gondii Immunity and Tumor Immunotherapy

Tumor-specific Neutrophils Originating from Meninges Promote Glioblastoma

Toxoplasma gondii‐induced amyloid reduction and neuroimmune responses in Alzheimer’s disease

Intestinal microbiota imbalance resulted by anti-Toxoplasma gondii immune responses aggravate gut and brain injury

4D label-free proteomic analysis reveals key potential pathways of Toxoplasma invasion into the central nervous system

Toxoplasma Gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma Gondii

Transcriptome Sequencing Investigated the Tumor-Related Factors Changes After T. gondii Infection

A pre-existing Toxoplasma gondii infection exacerbates the pathophysiological response and extent of brain damage after traumatic brain injury in mice

The local microenvironment drives activation of neutrophils in human brain tumors

Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells

Toxoplasma gondii Infection of BALB/c Mice Perturbs Host Neurochemistry

Group 1 metabotropic glutamate receptor expression defines a T cell memory population during chronic Toxoplasma infection that enhances IFN-gamma and perforin production in the CNS

Toxoplasma gondii Impairs Myogenesis in vitro, With Changes in Myogenic Regulatory Factors, Altered Host Cell Proliferation and Secretory Profile

Deficiency in astrocyte CCL2 production reduces neuroimmune control of Toxoplasma gondii infection

Toxoplasma gondii infection and its implications within the central nervous system

Toxoplasma Gondii Induces Blood-Brain Barrier Dysfunction in a Human Stem Cell- Derived Model